Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride.
We report on a Kenyan woman who developed bullous erythema multiforme, in association with Malarone treatment.
Remich
Shon A
SA
United States Army Medical Research Unit-Kenya (USAMRU-K), Walter Reed Project, Kisumu, Kenya.
Otieno
Walter
W
Polhemus
Mark E
ME
Ogutu
Bernhards
B
Walsh
Douglas S
DS
D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D053626:Atovaquone / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D004892:Erythema Multiforme / Q000209:etiology*; D005260:Female; D006801:Humans; D007630:Kenya; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D008875:Middle Aged; D002727:Proguanil / Q000008:administration & dosage / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone